Ives Drugs ( India) Pvt.Ltd., a active private limited company, was established on 17 April 1986 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1986PTC003375. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹4.80 Cr and a paid-up capital of ₹3.20 Cr.
It upholds a compliant status. Employing 213 professional, Its leadership includes Nitesh Dani (Director), Gaurav Airen (Director), Satish Mangal (Director). Past directors included Narendrakumar Mangilal Dani, Ramchandra Airen. It holds ₹41.21 Cr open charges and ₹10.09 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 504 Chetak Centre 12/2,,R.N.T.Marg, Indore, Madhya Pradesh, 452001.
U24232MP1986PTC003375
003375
17 April 1986
₹4.80 Cr
₹3.20 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Ives Drugs ( India) Pvt.Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitesh Dani | Director | 23 Mar 2021 | Current |
| Gaurav Airen | Director | 23 Mar 2021 | Current |
| Satish Mangal | Director | 17 Sep 1986 | Current |
| Mahendra Kumar Garg | Director | 17 Sep 1986 | Current |
| Ramchandra Airen | Director | 17 Apr 1986 | Current |
| Mani Shankar Pandey | Whole-Time Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 09 Mar 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ives Drugs ( India) Pvt.Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 0.05% increase. The company also saw a substantial improvement in profitability, with a 139.46% increase in profit. The company's net worth Soared by an impressive increase of 293.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ives Drugs ( India).Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹412,102,000.00
₹100,926,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2023 | City Union Bank Limited | ₹0.09 M | Open |
| 18 Oct 2023 | Hdfc Bank Limited | ₹19.75 Cr | Open |
| 26 Oct 2018 | Others | ₹1.13 M | Open |
| 27 Jun 2011 | City Union Bank Limited | ₹20.89 Cr | Open |
| 02 May 1987 | Madhya Pradesh Financial Corporation | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Ives Drugs ( India).Ltd. has a workforce of 213 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ives Drugs ( India).Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ives Drugs ( India).Ltd.'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 19.75 Cr registered on 18 Oct 2023 with Charge ID 100802006 was modified on 07 Jul 2025. was completed.
Progress on Mani Shankar Pandey was appointed as a Whole-time director was appointed as a Whole-time director on 01 Apr 2025 & has been associated with this company since 8 months . was documented.
Progress on Ives Drugs ( India) Pvt.Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ives Drugs ( India) Pvt.Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
Progress on A charge with City Union Bank Limited amounted to Rs. 0.01 Cr with Charge ID 100839300 was registered on 05 Dec 2023. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 19.75 Cr with Charge ID 100802006 was registered on 18 Oct 2023. was documented.
The CIN of Ives Drugs ( India) Pvt.Ltd. is U24232MP1986PTC003375.
Ives Drugs ( India) Pvt.Ltd. is headquartered at 504 Chetak Centre 12/2,,R.N.T.Marg, Indore, Madhya Pradesh, 452001.
Ives Drugs ( India) Pvt.Ltd. was incorporated on 17 April 1986.
The current directors of Ives Drugs ( India) Pvt.Ltd. are
The primary industry of Ives Drugs ( India) Pvt.Ltd. is Manufacturing.
Ives Drugs ( India) Pvt.Ltd. is unlisted.
The authorized capital of Ives Drugs ( India) Pvt.Ltd. is ₹4.80 Cr, and the paid-up capital is ₹3.20 Cr.
The compliance status of Ives Drugs ( India) Pvt.Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX